(Q74350013)

English

Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

scientific article published on 01 July 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Sirohi B

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Powles R

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kulkarni S

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Rudin C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Saso R

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lal R

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Singhal S

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Mehta J

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Horton C

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Treleaven J

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

29-37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498741%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703093

0 references

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

A cellulose acetate immunofixation technique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive treatment of multiple myeloma and criteria for complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of Ranks in One-Criterion Variance Analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulins in Clinical Chemistry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan for multiple myeloma: long-term follow-up data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703093

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74350013&oldid=1756355964"